Learn More


 
MBA Tools
MBA Glossary

 


Arena Pharmaceuticals, Inc. - ARNA - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 12, 2013

 

Arena Pharmaceuticals, Inc. - SIC # 8731

Ticker Exchange SIC # Website Latest Ticker
ARNA Nasdaq 8731 http://www.arenapharm.com 7.98 Stock Down -0.02

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Arena Pharmaceuticals, Inc.

25 Belt-Busting Obesity Facts - May 18th, 2013 6:01 am
ARENA PHARMACEUTICALS INC Financials - May 17th, 2013 11:04 am
Arena Outlines Belviq Launch And Goals - May 17th, 2013 12:01 am
Vivus - Mild Drama Continues - May 15th, 2013 8:18 am
Will Obesity Drugs Gain Soon? - May 15th, 2013 6:42 am
Looking at Arena Following Sell-Off - May 14th, 2013 3:49 am
Shorting Arena Is Not a Good Idea Now - May 13th, 2013 11:16 pm
Arena, Vivus, And Off-Label Prescriptions - May 13th, 2013 11:08 pm
Vivus Shifting Gears - May 10th, 2013 12:07 am
For Arena, Sales Is Key - May 9th, 2013 10:21 pm
Is the Golden Age of Blockbusters Over? - May 9th, 2013 6:16 pm
ARNA Sheds Light on Belviq Launch - May 9th, 2013 1:20 pm


View All Current Headlines >>

Bookmark and Share
facebooktwitter